Vitaccess Real MG Registry
ConditionMyasthenia Gravis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorVitaccess Ltd
About this trial
Vitaccess Real MG (VRMG) is a patient registry designed to capture longitudinal observational data on myasthenia gravis (MG), its treatment, and impact on symptoms, daily activities, and quality of life (QoL). The duration of the registry is 10 years from launch, and approximately 600 patients will be recruited in the US and Europe with no defined upper limit. The registry will link relevant patient- and healthcare professional (HCP)-reported data with clinical data from medical records.
Patients will be recruited at clinical sites in all participating countries. In the US only, patients can additionally be recruited via community neurologists or direct-to-patient recruitment.
Eligibility criteria
Qualifiers
Adult (age ≥18 years) with a clinically-confirmed diagnosis of myasthenia gravis (MG).
Resident in one of the scope countries.
Access to a smartphone/tablet/computer/laptop
Willing and able to provide informed consent in their local language to take part in the study.
Disqualifiers
Participation in a clinical trial at the time of study enrolment.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov